Clinicopathological utility of sialoglycoconjugates in diagnosing and treating colorectal cancer

doi:10.3748/wjg.v20.i20.6123

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 20

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6602)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

480

WORD

218

HTML

3453

Figures (1-2)

266

Tables (1-1)

216

Sum=4633

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1005

Download

964

Sum=1969

May 28, 2014 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. May 28, 2014; 20(20): 6123-6132
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6123

Full Size Figure Download Figure

Figure 1 Relationship between altered expression of sialoglycoconjugates and various steps of metastasis. EGFR: Epidermal growth factor receptor.

Citation: Inagaki Y, Gao J, Song P, Kokudo N, Nakata M, Tang W. Clinicopathological utility of sialoglycoconjugates in diagnosing and treating colorectal cancer. World J Gastroenterol 2014; 20(20): 6123-6132
URL: https://www.wjgnet.com/1007-9327/full/v20/i20/6123.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i20.6123